相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Deborah Rudin et al.
EXPERIMENTAL NEUROLOGY (2021)
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2020)
A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
Martin Korsbak Madsen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Designer drugs: mechanism of action and adverse effects
Dino Luethi et al.
ARCHIVES OF TOXICOLOGY (2020)
Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems
Dino Luethi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption
Katalin Kovacs et al.
JOURNAL OF FORENSIC AND LEGAL MEDICINE (2019)
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters
Amy J. Eshleman et al.
PSYCHOPHARMACOLOGY (2019)
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
Dino Luethi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
Dino Luethi et al.
NEUROPHARMACOLOGY (2018)
Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP
Cuimei Liu et al.
DRUG TESTING AND ANALYSIS (2017)
Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats
Michael B. Gatch et al.
PSYCHOPHARMACOLOGY (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
Amy J. Eshleman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1
Linda D. Simmler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
4F-PBP (4′-fluoro-α-pyrrolidinobutyrophenone), a new substance of abuse: Structural characterization and purity NMR profiling
Helena Gaspar et al.
FORENSIC SCIENCE INTERNATIONAL (2015)
'Second-Generation' Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function
Kusumika Saha et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives
Michael B. Gatch et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
The new drug phenomenon
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2014)
A 3-year review of new psychoactive substances in casework
Simon Elliott et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project
Anders Helander et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
Michael H. Baumann et al.
JOURNAL OF NEUROSCIENCE (2014)
Bath salts and synthetic cathinones: An emerging designer drug phenomenon
Christopher L. German et al.
LIFE SCIENCES (2014)
Pharmacology of novel synthetic stimulants structurally related to the bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)
Julie A. Marusich et al.
NEUROPHARMACOLOGY (2014)
MDMA enhances emotional empathy and prosocial behavior
Cedric M. Hysek et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Toxicity and death following recreational use of 2-pyrrolidino valerophenone
Celine Eiden et al.
CLINICAL TOXICOLOGY (2013)
Prevalence and co-existence of active components of legal highs'
Dariusz Zuba et al.
DRUG TESTING AND ANALYSIS (2013)
Designer cathinones-An emerging class of novel recreational drugs
Jolanta B. Zawilska et al.
FORENSIC SCIENCE INTERNATIONAL (2013)
Analysis of Synthetic Cathinones Commonly Found in Bath Salts in Human Performance and Postmortem Toxicology: Method Development, Drug Distribution and Interpretation of Results
Laureen J. Marinetti et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2013)
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans
C. M. Hysek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Analysis of First and Second Generation Legal Highs for Synthetic Cannabinoids and Synthetic Stimulants by Ultra-Performance Liquid Chromatography and Time of Flight Mass Spectrometry
Kevin G. Shanks et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2012)
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Duloxetine Inhibits Effects of MDMA (Ecstasy) In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
Cedric M. Hysek et al.
PLOS ONE (2012)
Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
Cedric M. Hysek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States
Henry A. Spiller et al.
CLINICAL TOXICOLOGY (2011)
Analysis of NRG 'legal highs' in the UK: Identification and formation of novel cathinones
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2011)
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology
John P. Kelly
DRUG TESTING AND ANALYSIS (2011)
Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service
D. James et al.
EMERGENCY MEDICINE JOURNAL (2011)
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
Benjamin Di Cara et al.
JOURNAL OF NEUROSCIENCE (2011)
In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat
Michael H. Baumann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Bath Salts Intoxication
Edward A. Ross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro
Stephane Doly et al.
JOURNAL OF NEUROSCIENCE (2008)
Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure:: 4'-Methyl-α-pyrrolidinohexanophenone and 4'-methyl-α-pyrrolidinobutyrophenone
Folker Westphal et al.
FORENSIC SCIENCE INTERNATIONAL (2007)
Identification of cytochrome P450 enzymes involved in the metabolism of 4′-methoxy-α-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes
D Springer et al.
XENOBIOTICA (2003)
Metabolism and toxicological detection of the new designer drug 4′-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry
D Springer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
分享论文
